TNF and inflammatory bowel disease: The introduction of biologics during the last 20 years has revolutionized the treatment of IBD, and several anti-TNF monoclonal antibodies (mAbs) (including infliximab, adalimumab, certolizumab pegol, and golimumab) are commonly used.